Legend Biotech Corporation (LEGN) announced Loss for fourth quarter that beat the Street estimates.
The company's earnings came in at -$144.818 million, or -$0.40 per share. This compares with -$135.876 million, or -$0.41 per share, in last year's fourth quarter.
Analysts on average had expected the company to earn -$0.83 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 187.6% to $79.464 million from $27.633 million last year.
Legend Biotech Corporation earnings at a glance (GAAP) :
-Earnings (Q4): -$144.818 Mln. vs. -$135.876 Mln. last year.-EPS (Q4): -$0.40 vs. -$0.41 last year.-Revenue (Q4): $79.464 Mln vs. $27.633 Mln last year.
For comments and feedback contact: editorial@rttnews.com
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.